15:00 - 15:03 | Welcome and introduction: Meletios Dimopoulos
15:03 - 15:28 | New insight into the biology of MM: from clonal evolution to new treatment options: Nikhil C. Munshi
15:28 - 15:58 | Continuous therapy to enhance ASCT: expert perspectives: Pieter Sonneveld
15:58 - 16:28 | Multiple options for RRMM: why pick proteasome inhibition? Meletios Dimopoulos
16:28 - 16:30 | Conclusions and summary: Meletios Dimopoulos
Todos os direitos reservados